Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Glomerulonephritis, Membranous

• REmission in Membranous Nephropathy International Trial (REMIT)
• A Clinical Study of MIL62 in Primary Membranous Nephropathy
• Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
• Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
• Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy
• An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases.
• A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
• A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
• Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
• A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
• Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
• Rituximab or Cyclophosphamide Combined With Steroids in Idiopathic Membranous Nephropathy
• A Clinical Study of MIL62 in Primary Membranous Nephropathy
• BCX9930 for the Treatment of C3G, IgAN, and PMN (RENEW)
• Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy
• Obinutuzumab in Primary MN
• Rescue Therapy With the Human Anti-CD38 Antibody MOR202 (Felzartamab) in Patients With Membranous Nephropathy Who Failed Anti-CD20 Target Therapy
• Different Immunosuppressive Treatment in iMN
• Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
• Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
• A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
• The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
• A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN
• Multitarget Therapy for Idiopathic Membranous Nephropathy
• A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
• Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
• Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
• Belimumab With Rituximab for Primary Membranous Nephropathy
• Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
• Personalized Medicine for Membranous Nephropathy
• Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
• The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.
• Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
• Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)
• Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
• Adrenocorticotropic Hormone in Membranous Nephropathy
• Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
• Study on the Therapeutic Effect of TCM Treatment for MDR MN
• A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy
• Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
• Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
• Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
• Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
• A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
• Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
• Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
• MEmbranous Nephropathy Trial Of Rituximab
• Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
• Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
• Aliskiren in Patients With Idiopathic Membranous Nephropathy
• A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
• Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
• Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
• Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
• Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
• To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
• Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
• Rituximab in Membranous Nephropathy
• Rituximab in the Treatment of Idiopathic Membranous Nephropathy
• Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
• A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
• Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
• Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
• Mycophenolate Mofetil in Membranous Nephropathy
• Treatment of Patients With Idiopathic Membranous Nephropathy
• Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy